Sale Of The Entire Shareholding Held By The Company In Nueclear Healthcare Limited
Announcement under Regulation 30 (LODR)-Acquisition
Outcome Of The Board Meeting Held On Monday, September 21, 2026
Communication Received From API Holdings Limited Regarding Approval Of Scheme Of Amalgamation Of Docon Technologies Private Limited With API Holdings Limited
Disclosure under Regulation 30A of LODR
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Communication Received From Promoter Regarding Release Of Pledge
Communication Received From Promoter Regarding Sale of Equity Shares
Proposed restructuring of the radiology business of Nueclear Healthcare Limited (Wholly Owned Subsidiary)
Re-Appointment Of Internal Auditor Of The Company
Outcome of Board Meeting 23.07.2026
Board Meeting Prior Intimation
Share Reconciliation Capital Audit Report
Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Outcome_26th AGM_MOA_Signed
Outcome_26th AGM_Auditors Appointment_Signed
Intimation of Closure of Trading Window – June 30, 2026
Corporate Action – Recommendation of Final Dividend
Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
